Quest Partners LLC Purchases 5,361 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Quest Partners LLC increased its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 263.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,397 shares of the construction company’s stock after purchasing an additional 5,361 shares during the period. Quest Partners LLC’s holdings in Aspen Aerogels were worth $205,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Point72 Hong Kong Ltd purchased a new position in shares of Aspen Aerogels in the 2nd quarter worth $84,000. nVerses Capital LLC bought a new stake in shares of Aspen Aerogels in the 2nd quarter worth about $95,000. Quent Capital LLC bought a new stake in shares of Aspen Aerogels in the 3rd quarter worth about $118,000. Point72 DIFC Ltd purchased a new position in shares of Aspen Aerogels during the 2nd quarter worth about $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new position in shares of Aspen Aerogels during the 2nd quarter worth about $145,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 11.58 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 4.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on ASPN shares. TD Cowen lifted their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. HC Wainwright reaffirmed a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Benchmark reaffirmed a “buy” rating and set a $14.00 price target on shares of Aspen Aerogels in a research note on Thursday, August 8th. Piper Sandler dropped their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, Roth Mkm lowered their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $28.70.

Aspen Aerogels Price Performance

Shares of ASPN opened at $14.48 on Thursday. The company has a 50 day moving average price of $20.48 and a 200-day moving average price of $24.08. Aspen Aerogels, Inc. has a fifty-two week low of $10.31 and a fifty-two week high of $33.15. The stock has a market capitalization of $1.19 billion, a PE ratio of 1,449.45 and a beta of 2.21. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.